DexCom
DXCM
$3.81 (-5.22%)
1D
1W
3M
1Y
5Y
ALL
Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 2 hours ago • DXCM
DexCom Q2: Surprising Earnings Miss With Hints Of Competitive PressuresInvestopedia • 6 hours ago • DXCM
Watch These Dexcom Price Levels as Stock Plunges After Guidance SlashedBusiness Wire • 6 hours ago • DXCM
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of DexCom, Inc. (DXCM) on Behalf of InvestorsSeeking Alpha • 7 hours ago • DXCM
DexCom, Inc. (DXCM) Q2 2024 Earnings Call TranscriptZacks Investment Research • 9 hours ago • DXCM
DexCom (DXCM) Q2 Earnings Surpass EstimatesCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.